Dendritic Cell Vaccine for Patients With Brain Tumors
Last updated on July 2021Recruitment
- Recruitment Status
- Active, not recruiting
Summary
- Conditions
- Anaplastic Astro-oligodendroglioma
- Anaplastic Astrocytoma
- Glioblastoma
- Glioma
- Type
- Interventional
- Phase
- Phase 2
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment
Participation Requirements
- Age
- Between 18 years and 70 years
- Gender
- Both males and females
Description
Not Provided
Not Provided
Tracking Information
- NCT #
- NCT01204684
- Collaborators
- Not Provided
- Investigators
- Not Provided